# An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease

> **NCT06177431** · PHASE1 · COMPLETED · sponsor: **Neurizon Therapeutics Limited** · enrollment: 12 (actual)

## Conditions studied

- Motor Neuron Disease

## Interventions

- **DRUG:** Monepantel

## Key facts

- **NCT ID:** NCT06177431
- **Lead sponsor:** Neurizon Therapeutics Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-13
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-06-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06177431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06177431, "An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06177431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*